Literature DB >> 7554234

Permeability of the developing blood-brain barrier to 14C-mannitol using the rat in situ brain perfusion technique.

J E Preston1, H al-Sarraf, M B Segal.   

Abstract

The brain penetration of 14C-mannitol was investigated using a bilateral in situ brain perfusion technique followed by capillary depletion analysis. This technique measures the uptake of slowly penetrating solutes in the absence of the systemic circulation, and separates accumulation in brain endothelial cells from uptake into brain parenchyma. Penetration of 14C-mannitol was linear up to 30 min in rats aged 1, 2, 3 weeks and in adults. The brain mannitol space was higher in 1-week-old neonatal rats compared with adults (P < 0.05) and was due to a greater initial volume of distribution (Vi) for mannitol in the neonates, and not due to an elevated transfer rate (K(in)). Thirty percent of mannitol in the neonatal brain was associated with the capillary containing fraction, whereas in the adult only 13% was found in this fraction. This suggests that the permeability of the blood-brain barrier to mannitol does not change significantly with development but that more mannitol is associated with endothelial cells in the neonate. An investigation of 14C-glycine uptake was also carried out, and unlike mannitol the K(in) was greater in the neonate compared to the adult suggesting an elevated rate of transfer for this amino acid into the neonatal rat brain.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7554234     DOI: 10.1016/0165-3806(95)00060-q

Source DB:  PubMed          Journal:  Brain Res Dev Brain Res        ISSN: 0165-3806


  21 in total

1.  An isolated in-situ rat head perfusion model for pharmacokinetic studies.

Authors:  K A Foster; G D Mellick; M Weiss; M S Roberts
Journal:  Pharm Res       Date:  2000-02       Impact factor: 4.200

Review 2.  Peptides at the blood brain barrier: Knowing me knowing you.

Authors:  Thomas P Davis; Thomas J Abbruscato; Richard D Egleton
Journal:  Peptides       Date:  2015-04-30       Impact factor: 3.750

3.  Administration of sesamol improved blood-brain barrier function in streptozotocin-induced diabetic rats.

Authors:  R L VanGilder; K A Kelly; M D Chua; R L Ptachcinski; Jason D Huber
Journal:  Exp Brain Res       Date:  2009-06-30       Impact factor: 1.972

4.  Regulation of brain copper homeostasis by the brain barrier systems: effects of Fe-overload and Fe-deficiency.

Authors:  Andrew D Monnot; Mamta Behl; Sanna Ho; Wei Zheng
Journal:  Toxicol Appl Pharmacol       Date:  2011-02-19       Impact factor: 4.219

5.  Regulation of copper transport crossing brain barrier systems by Cu-ATPases: effect of manganese exposure.

Authors:  Xue Fu; Yanshu Zhang; Wendy Jiang; Andrew Donald Monnot; Christopher Alexander Bates; Wei Zheng
Journal:  Toxicol Sci       Date:  2014-03-10       Impact factor: 4.849

6.  Increased blood-brain barrier permeability and altered tight junctions in experimental diabetes in the rat: contribution of hyperglycaemia and matrix metalloproteinases.

Authors:  B T Hawkins; T F Lundeen; K M Norwood; H L Brooks; R D Egleton
Journal:  Diabetologia       Date:  2006-12-02       Impact factor: 10.122

7.  Assessment of the first and second generation antihistamines brain penetration and role of P-glycoprotein.

Authors:  Tanja Obradovic; Glenn G Dobson; Tomotaka Shingaki; Thomas Kungu; Ismael J Hidalgo
Journal:  Pharm Res       Date:  2006-12-19       Impact factor: 4.200

8.  NOX2 inhibition with apocynin worsens stroke outcome in aged rats.

Authors:  Kimberly A Kelly; Xinlan Li; Zhenjun Tan; Reyna L VanGilder; Charles L Rosen; Jason D Huber
Journal:  Brain Res       Date:  2009-07-25       Impact factor: 3.252

9.  Reoxygenation stress on blood-brain barrier paracellular permeability and edema in the rat.

Authors:  Ken A Witt; Karen S Mark; Karin E Sandoval; Thomas P Davis
Journal:  Microvasc Res       Date:  2007-06-26       Impact factor: 3.514

10.  Copper transport to the brain by the blood-brain barrier and blood-CSF barrier.

Authors:  Byung-Sun Choi; Wei Zheng
Journal:  Brain Res       Date:  2008-11-05       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.